NCT06473246: A Study to Determine Safety, Pharmakokinetics and Efficacy of the Different Doses of VL-SE-01 in Healthy Participants. |
|
|
| Not yet recruiting | N/A | 200 | RoW | CBD Isolate (25 mg/0.5 ml), CBD Isolate (40 mg/0.5 ml), CBD Isolate (50 mg/0.5 ml), CBD Broad Extract (50 mg/0.5 ml), Placebo | Vedic Lifesciences Pvt. Ltd. | Healthy Population | 10/25 | 10/25 | | |